Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Authors: Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

Source: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/12/5/e008025.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/ae1324671e874fbf8b0558f501e18cfa

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

Authors: Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto

Source: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/12/4/e008880.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/71dfb5bed3424781825b31ac8a5284ee

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

Authors: Sharad Goyal, Howard L Kaufman, Andrew Zloza, Ann W Silk, Vineet Gupta, Shang-Jui Wang, Bruce G Haffty, Nicole R LeBoeuf, Sachin R Jhawar, Jose A Guevara-Patino, Timothy M Kuzel, Jochen Reiser, Aditya Thandoni, Praveen K Bommareddy, Jenna H Newman, Amanda L Marzo, Preston Daniels, Devora Schiff, Darrion Mitchell, Christopher Simmons, Ahmed Lasfar, Eileena F Giurini

Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/11/7/e006780.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/aa466472bc1745428fedfc56b28b3f77

Clinical landscape of oncolytic virus research in 2020

Authors: Howard L Kaufman, Rizwan Haq, Nicholas Macedo, David M Miller

Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/8/2/e001486.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/394a80a82f914be789cf77838206609d

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

Authors: Lisa H Butterfield, Howard L Kaufman, Steven A Rosenberg, Simon Turcotte, Robert L Ferris, Craig L Slingluff, David Byrd, Jyothi Sethuraman, Brian Gastman, Michael Lim, Michael T Lotze, Mokenge Malafa, Adekunle Odunsi, Fumito Ito, Genevieve Boland, Pranav Murthy, Adam Berger, Haider Mahdi, Piyush K Agarwal, Stephen Broderick, Peter E Fecci, Yuman Fong, Stephanie L Goff, Matthew M Grabowski, Carol D Morris, Rogerio I Neves, Sara I Pai, Sangeetha Prabhakaran, Ragheed Saoud, Joseph Skitzki, Vernon K Sondak, John B Sunwoo, Cecilia CS Yeung

Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/8/2/e001583.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/20db5803d1fa467cab907b6e8216be86

Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit

Authors: Antonia R Sepulveda, Howard L Kaufman, Robert Carlson, Sara Pai, David Blaisdell, Rachel Brodie, Heidi Finnes, Michele Galioto, Roxanne E Jensen, Tom Valuck

Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/8/1/e000112.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/91fc6177e5364df5b7c8576ec240c6e1

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Authors: James L Gulley, Julie R Brahmer, Pedro J Romero, Francesco M Marincola, Charles G Drake, Stefani Spranger, Lisa H Butterfield, Douglas G McNeel, Alessandra Cesano, Thomas F Gajewski, Howard L Kaufman, Bernard A Fox, Leisha A Emens, Mario Sznol, Tanja D de Gruijl, Daniel S Chen, Patrick Hwu, Paolo Antonio Ascierto, Walter J Urba, Jon M Wigginton, Robert O Dillman, Michael B Atkins, Kim A Margolin, Paul M Sondel, Michael T Lotze, Ana Carrizosa Anderson, Ernest C Borden, David Kaufman, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, George J Weiner, Jeffrey S Weber, F Stephen Hodi Jr

Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/8/1/e000878.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/0c91fa8ce43c41b59e024c5990dc73a7

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Authors: Udo S Gaipl, Dmitriy Zamarin, Felipe Prosper, Francesco M Marincola, Alessandra Cesano, Howard L Kaufman, Laurence Zitvogel, Tim Illidge, Taha Merghoub, Sandra Demaria, Abhishek D Garg, Patrizia Agostinis, James W Hodge, George Coukos, Akseli Hemminki, Öystein Rekdal, Jian Han, John Stagg, Sarah Warren, Lorenzo Galluzzi, Dobrin Draganov, Silvia C Formenti, Mark J Smyth, Radek Špíšek, Michael T Lotze, Takahiro Yamazaki, Guido Kroemer, Daolin Tang, Eric Deutsch, Jitka Fucikova, Sofia R Gameiro, Ilio Vitale, Sandy Adjemian, Aitziber Buqué Martinez, Timothy A Chan, Richard L Edelson, Lucia Gabriele, Encouse Golden, Kevin J Harrington, Dewan Md Sakib Hossain, Michael Karin, Oliver Kepp, Juan Jose Lasarte, Sherene Loi, Gwenola Manic, Alan A Melcher, Karen L Mossman, Maria Rescigno, Chiara Riganti, Antonella Sistigu, Bryan E Strauss, Kazuki Tatsuno, Stefaan W van Gool, Peter Vandenabeele

Source: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/8/1/e000337.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/a9d90895f1e544d9989ad2cde51f79c0

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

Authors: Josef W. Goldufsky, Preston Daniels, Michael D. Williams, Kajal Gupta, Bruce Lyday, Tony Chen, Geeta Singh, Howard L. Kaufman, Andrew Zloza, Amanda L. Marzo

Source: Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)

Subject Terms: Dengue virus, Oncolytic, Immunotherapy, Melanoma, Breast cancer, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1479-5876

Access URL: https://doaj.org/article/9921b474221c44f481cdbc4c7d3b0bc3

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

Authors: Ann W. Silk, Brendan Curti, Jennifer Bryan, Tracie Saunders, Weichung Shih, Michael P. Kane, Phoebe Hannon, Christopher Fountain, Jessica Felcher, Andrew Zloza, Howard L. Kaufman, Janice M. Mehnert, David F. McDermott

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: melanoma, interleukin-2, cytokine, pembrolizumab, combination immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1108341/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/e180df27cd2646ef8743d38d18aaff92

Talimogene Laherparepvec: Moving From First-In-Class to Best-In-Class

Authors: Howard L. Kaufman, Sophia Z. Shalhout, Gail Iodice

Source: Frontiers in Molecular Biosciences, Vol 9 (2022)

Subject Terms: biomarker, cancer, immunotherapy, oncolytic virus (OV), treatment, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmolb.2022.834841/full; https://doaj.org/toc/2296-889X

Access URL: https://doaj.org/article/f95cca8078b04632a84b37342b1cb4d5

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

Authors: Suzanne Thomas, Linta Kuncheria, Victoria Roulstone, Joan N. Kyula, David Mansfield, Praveen K. Bommareddy, Henry Smith, Howard L. Kaufman, Kevin J. Harrington, Robert S. Coffin

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-17 (2019)

Subject Terms: Oncolytic viruses, Herpes simplex-1, Immunotherapy, Anenestic effect, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0682-1; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/46728252723447c4a956c222a4501deb

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

Authors: Robert H. I. Andtbacka, Frances Collichio, Kevin J. Harrington, Mark R. Middleton, Gerald Downey, Katarina Ӧhrling, Howard L. Kaufman

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)

Subject Terms: Efficacy, Final analysis, Melanoma, Overall survival, Talimogene laherparepvec, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0623-z; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/1127b00ac05c4e56bcaae9dafbb280fc

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Authors: Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-23 (2019)

Subject Terms: Cancer immune responsiveness (CIR), Immune checkpoint inhibitor (ICI), Immune oncology (IO), Immunotherapy, Tumor microenvironment (TME), Tumor mutational burden (TMB), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0602-4; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/864f25d06ad04690a4ef2014434f0547

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Authors: Howard L. Kaufman, Michael B. Atkins, Prasun Subedi, James Wu, James Chambers, T. Joseph Mattingly, Jonathan D. Campbell, Jeff Allen, Andrea E. Ferris, Richard L. Schilsky, Daniel Danielson, J. Leonard Lichtenfeld, Linda House, Wendy K. D. Selig

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)

Subject Terms: Immunotherapy, Immuno-oncology, Value, Patient experience, Patient reported outcomes (PROs), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0594-0; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/32134812e74f40ba9ecc09ba55ae0b31

Two roads for oncolytic immunotherapy development

Authors: Howard L. Kaufman, Praveen K. Bommareddy

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0515-2; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/639dae61c57c458287a00f4d26a00b8f

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

Authors: Paolo A. Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H. Butterfield, David Carbone, Bruno Daniele, Robert Ferris, Bernard A. Fox, Jérôme Galon, Cesare Gridelli, Howard L. Kaufman, Christopher A. Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M. Paulos, Marco Ruella, Ryan Sullivan, Hassane Zarour, Igor Puzanov

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)

Subject Terms: Immunotherapy, Checkpoint inhibitors, Cancer vaccines, Adoptive cell transfer combination therapy, Biomarkers, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0377-z; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/ae6cf35179f442a684e418cfea0ba27f

Immune oncology, immune responsiveness and the theory of everything

Authors: Tolga Turan, Deepti Kannan, Maulik Patel, J. Matthew Barnes, Sonia G. Tanlimco, Rongze Lu, Kyle Halliwill, Sarah Kongpachith, Douglas E. Kline, Wouter Hendrickx, Alessandra Cesano, Lisa H. Butterfield, Howard L. Kaufman, Thomas J. Hudson, Davide Bedognetti, Francesco Marincola, Josue Samayoa

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)

Subject Terms: Cancer immunotherapy, Checkpoint inhibitors, Immune resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0355-5; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/10180b8808134fbc95b5f5c4b272dbfe

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

Authors: Ryan J. Sullivan, Michael B. Atkins, John M. Kirkwood, Sanjiv S. Agarwala, Joseph I. Clark, Marc S. Ernstoff, Leslie Fecher, Thomas F. Gajewski, Brian Gastman, David H. Lawson, Jose Lutzky, David F. McDermott, Kim A. Margolin, Janice M. Mehnert, Anna C. Pavlick, Jon M. Richards, Krista M. Rubin, William Sharfman, Steven Silverstein, Craig L. Slingluff, Vernon K. Sondak, Ahmad A. Tarhini, John A. Thompson, Walter J. Urba, Richard L. White, Eric D. Whitman, F. Stephen Hodi, Howard L. Kaufman

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-23 (2018)

Subject Terms: Guidelines, Immunotherapy, Melanoma, Treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0362-6; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/4608673a241f46ca9625955f197bdebe

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

Authors: Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-6 (2018)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0335-9; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/c8d6ef5b888c4553a6243bc67700541c